Latest news
Loading news…
Virion Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Newark, Delaware, United States Founded 2018 11-50 employees For Profit
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $10M to $50M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 38
- IT spend
- $83K
Company Info
- Founded
- 2018
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 34
- HQ
- Newark, Delaware, United States
- Region
- Greater Philadelphia Area, East Coast, Southern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 3.2
- Trend (30d)
- 4.7
- Trend (90d)
- 3.2
- Last leadership hire
- Nov 22, 2021
Key People at Virion Therapeutics
President & CEO
Scientific Founder
5
professional contacts at Virion Therapeutics
Contact execs at Virion Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Virion Therapeutics
Loading news…
FAQs about Virion Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.